PF-59983 |
REMDESIVIR Eva Pharma 100 mg Concentrado para solución para infusión I.V. |
2026-09-06 |
|
Eva Pharma for Pharmaceuticals and Medicals Appliances |
Egipto
|
ERETZ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60330 |
TERLIPRESINA ACETATO Ever Pharma 1 mg Solución inyectable |
2026-11-08 |
|
Ever Valinject GmbH |
Alemania
|
Bioplus Care Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-43958 |
TRAMADOL CLORHIDRATO Sandoz 100mg/2mL Solución inyectable |
2019-11-20 |
|
Sandoz GmbH |
Alemania
|
Farmalogsa |
Amicelco |
Novartis Farmacéutica, Sociedad Anónima (América Central) |
DASA |
Centro Distribuidor, Sociedad Anónima |
Norvanda Healthcare, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-49059 |
HEPARUBINA Cápsulas |
2029-03-18 |
|
Everest Pharm. Industrial Co. Ltd. |
Taiwán
|
Pharland |
Droguería Landívar |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26327 |
GAS-X 125 mg Tabletas masticables sabor cereza |
2006-07-12 |
|
Novartis Consumer Health S.A. |
Estados Unidos de América
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26024 |
EX-LAX 25 mg. grageas |
2006-05-14 |
|
Novartis Consumer Health S.A. |
Puerto Rico, Estados Unidos
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26026 |
EX-LAX 15 mg. tabletas chocolatadas masticables |
2006-05-14 |
|
Novartis Consumer Health S.A. |
Puerto Rico, Estados Unidos
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26772 |
GAS X 80 mg Tabletas masticables sabor menta. |
2006-08-10 |
|
Novartis Consumer Health S.A. |
Puerto Rico, Estados Unidos
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26325 |
GAS-X 125 mg Tabletas masticables sabor menta. |
2006-07-12 |
|
Novartis Consumer Health S.A. |
Puerto Rico, Estados Unidos
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26326 |
GAS X 80 mg Tabletas masticables sabor cereza |
2006-07-12 |
|
Novartis Consumer Health S.A. |
Puerto Rico, Estados Unidos
|
Novartis Farmaceutica S.A. (ac) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|